Therapeutic strategies for COVID-19: progress and lessons learned

The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous efforts to develop therapeutic strategies that target severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and/or human proteins to control viral infection, encompassing hundreds of potential drugs and thousands of pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guangdi, Hilgenfeld, Rolf, Whitley, Richard, De Clercq, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113999/
https://www.ncbi.nlm.nih.gov/pubmed/37076602
http://dx.doi.org/10.1038/s41573-023-00672-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113999/
https://www.ncbi.nlm.nih.gov/pubmed/37076602
http://dx.doi.org/10.1038/s41573-023-00672-y

Ejemplares similares